Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.80 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.80 |
| ▸ | LMNA | P02545 | 1/20 | 0.80 |
| ▸ | DGKA | P23743 | 1/20 | 0.68 |
| ▸ | LPAR1 | Q92633 | 8/20 | 0.68 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.68 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.68 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.68 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.66 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.66 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.66 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 2/20 | 0.58 |
| ▸ | CES2 | O00748 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28053366 | 0.97 | KDM4E (0.80) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Phosphoric Acid SCHEMBL28261779 | 0.93 | KDM4E (0.88) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Monoctanoin Component A SCHEMBL8404946 | 0.93 | KDM4E (0.88) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Glyceryl Monostearate SCHEMBL7999761 | 0.93 | KDM4E (0.88) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Glyceryl Monostearate SCHEMBL29144673 | 0.91 | KDM4E (0.85) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Glyceryl Monostearate SCHEMBL27702135 | 0.90 | LMNA (0.93) | KDM4EDUSP3MEN1KMT2ALMNA | |
| 2',3'-Dihydroxy Propyl Pentadecanoate SCHEMBL401287 | 0.89 | LMNA (1.00) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Glycerol Monolaurate SCHEMBL16042 | 0.89 | LMNA (1.00) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Octane SCHEMBL5181039 | 0.89 | LMNA (1.00) | KDM4EDUSP3MEN1KMT2ALMNA | |
| Glyceryl Monostearate SCHEMBL5719482 | 0.89 | LMNA (1.00) | KDM4EDUSP3MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717714-A | Chemiluminescence reinforcing agent, preparation method thereof and application thereof in chemiluminescence liquid | 大连博格林生物科技有限公司 | 2021-11-30 | — | — | CN | disclosed |
| US-9139766-B2 | Chemiluminescent compositions and enhancing reagents for chemiluminescence | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) | 2015-09-22 | — | — | US | disclosed |
| US-8883514-B2 | Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) | 2014-11-11 | — | — | US | disclosed |
| US-8563321-B2 | Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) | 2013-10-22 | — | — | US | disclosed |
| US-8557147-B2 | Chemiluminescent compositions, enhancing reagents for chemiluminescence and methods for the preparation and use thereof | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) | 2013-10-15 | — | — | US | disclosed |
| US-20120015446-A1 | Chemiluminescent Compositions, Enhancing Reagents for Chemiluminescence and Methods for the Preparation and Use Thereof | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) | 2012-01-19 | — | — | US | disclosed |
| US-20120003753-A1 | CHEMILUMINESCENT COMPOSITIONS, ENHANCING REAGENTS FOR CHEMILUMINESCENCE AND METHODS FOR THE PREPARATION AND USE THEREOF | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) | 2012-01-05 | — | — | US | disclosed |
| US-20120001136-A1 | CHEMILUMINESCENT COMPOSITIONS, ENHANCING REAGENTS FOR CHEMILUMINESCENCE AND METHODS FOR THE PREPARATION AND USE THEREOF | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (CN) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001136-A1 | CHEMILUMINESCENT COMPOSITIONS, ENHANCING REAGENTS FOR CHEMILUMINESCENCE AND METHODS FOR THE PREPARATION AND USE THEREOF | GUCY1B1, GUCY1A1, GUCY1A2 | KDM4E 449/4885DUSP3 2839/4885MEN1 2264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.